Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation (VIREAMIND)

Inclusion Criteria: Any patient consuming 10 to 40 cigarettes per day Woman or man aged 18 to 75 inclusive Substance use disorder according to the DSM5 classification Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person Having signed the informed consent form after having received written information. Exclusion Criteria: Disabling cognitive disorders Patient under 18 or over 75 years old. Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up Patient with addiction to another product. Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be randomized in the experimental group). Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in the study, subject to the judgment of the doctor Pregnant or breastfeeding woman Simultaneous participation in another trial Employee of the investigator or of the clinical trial site Patients protected by law Patients who do not speak the French language People not covered by state health insurance Patients who in the opinion of the investigator are unable to complete the questionnaires Patient claustrophobic or anxious about using the cabin Patient allergic to a molecule present in nicotine substitutes